Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 that is in Phase 2a clinical trial for the treatment of erectile dysfunction and under medical discovery for treating premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.
Frequently asked questions
What sector does Dicot AB (DICOT) operate in?
Dicot AB belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Dicot AB (DICOT) current stock price?
As of the latest data, Dicot AB stock price is SEK 0.20, with a previous close of SEK 0.20. Dicot AB gained SEK 0.00 in the last trading session, representing a 0.59% increase.
What is Dicot AB (DICOT) current market capitalization?
Dicot AB market cap is approximately 706.92 million.
What is Dicot AB (DICOT) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.03.
Does Dicot AB (DICOT) pay dividends?
No. Dicot AB does not pay a dividend.
What is Dicot AB (DICOT) beta (volatility) score?
Dicot AB has a beta of 0.858, meaning its volatility is roughly in line with the market.